Aclidinium: A long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD Stock Photo - Alamy
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long-Acting Dual Bronchodilators - LAMA/LABA Combo ... | GrepMed
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N - 2017 | Cochrane Library
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
New developments in inhaled therapy | Practice Nursing
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease - ScienceDirect
Navigating New Treatment Options for COPD | Consultant360
Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis | European Respiratory Society
Study design schematic. Abbreviations: LABA, long-actingβ 2 -agonist;... | Download Scientific Diagram
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Study design. Abbreviations: LAMA, long-acting muscarinic antagonist;... | Download Scientific Diagram
Case report timeline following CARE guidelines. LAMA, long acting... | Download Scientific Diagram
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Does my patient still need A long-acting inhaler? — PDC Rx
study design. Abbreviations: laBa, long-acting β-2 agonist; laMa,... | Download Scientific Diagram
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
